The only available automated test to determine the procoagulant activity of phospholipids.
This innovating test is an indirect marker of Tissue Factor exposure In Vivo.
STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control*
Rivaroxaban is a new oral anticoagulant developed by Bayer HealthCare and sold under the trade name Xarelto®. It is a direct factor Xa inhib...
How can haemophilia A and type 2N von Willebrand disease be distinguished? To answer this question, Stago has developed a new diagnostic too...
Diagnostica Stago, the worldwide leader in the field of Haemostasis is setting the standard of excellence, with cutting-edge technologies, products and customer service. United Kingdom is one of the countries where research is the most advanced in the field of coagulation and the demand for new technologies is great. In January 2005, the subsidiary Diagnostica Stago UK was opened.

Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diagnostic tools in looking for a way to improve prevention, understanding, diagnostic, treatment and follow-up of coagulation-related pathologies.
September 4-5, 2012
October 18 - 19, 2012
Did you know?
The name of Warfarin is a partial acronym for the Wisconsin Alumni Research Foundation, while Coumarin (4-hydroxycoumarin) is the form most generally prescribed.
Recent Jobs
We don't have any job openings at the moment. Please check back later. If you would still like to apply, you are welcome to send us an unsolicited application.
Apply